Rani Therapeutics Holdings (RANI) Market Capitalization (2021 - 2026)

Rani Therapeutics Holdings has reported Market Capitalization for 6 years, with the latest figure at $142.2 million in Q2 2026.

• On a quarterly basis, Market Capitalization rose 341.28% year-over-year to $142.2 million in Q2 2026; TTM through Jun 2026 was $142.2 million, a 341.28% increase from a year earlier, with the FY2025 full-year figure at $164.1 million, up 108.73% from the prior year.
• Market Capitalization was $142.2 million for Q2 2026 at Rani Therapeutics Holdings, up from $133.2 million in the prior quarter.
• The five-year high for Market Capitalization was $663.7 million in Q1 2022, with the low at $32.2 million in Q2 2025.
• Average Market Capitalization over 5 years is $210.8 million, with a median of $160.5 million recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Market Capitalization sank 83.24% in 2025, then surged 341.28% in 2026.
• Over 5 years, Market Capitalization stood at $291.5 million in 2022, then plunged by 42.88% to $166.5 million in 2023, then slumped by 52.77% to $78.6 million in 2024, then jumped by 108.73% to $164.1 million in 2025, then retreated by 13.34% to $142.2 million in 2026.
• The last three Market Capitalization figures came in at $142.2 million (Q2 2026), $133.2 million (Q1 2026), and $164.1 million (Q4 2025), per Business Quant data.